Glenmark recalls 1,200 bottles of generic hypertension drug in US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA). The New Jersey-based arm of the drug firm is recalling 1,200 bottles of Trandolapril and Verapamil Hydrochloride extended-release tablets, as per the latest Enforcement Report of the US health regulator. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 28, 2023 Category: Pharmaceuticals Source Type: news
Verapamil Partially Preserves C-Peptide Secretion in Children With T1DM
TUESDAY, March 7, 2023 -- Verapamil partially preserves stimulated C-peptide secretion at 52 weeks after diagnosis among children with newly diagnosed type 1 diabetes, according to a study published online Feb. 24 in the Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 7, 2023 Category: Pharmaceuticals Source Type: news
Old Drug Verapamil May Have New Use in Type 1 Diabetes Old Drug Verapamil May Have New Use in Type 1 Diabetes
In randomized trial, the old cardiac agent slowed the destruction of insulin-producing beta cells in youth with new-onset type 1 diabetes.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 27, 2023 Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news
R-Form Verapamil Added to Ongoing Metformin Therapy in T2D R-Form Verapamil Added to Ongoing Metformin Therapy in T2D
A new study examines the potential of this combination therapy as a treatment option for patients with type 2 diabetes who do not adequately respond to metformin alone.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Medication helps protect insulin production in type 1 diabetes
A drug approved to treat high blood pressure, called verapamil, protected insulin-producing cells in the pancreas in people with type 1 diabetes. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - March 22, 2022 Category: Consumer Health News Source Type: news
Blood pressure medication shows benefits treating Type 1 diabetes
Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications. Patients taking the oral blood pressure medication not only required less daily insulin two years after first diagnosis of the disease, but also showed evidence of surprising immunomodulatory benefits. (Source: World Pharma News)
Source: World Pharma News - March 3, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Armas Pharmaceuticals Adds Four Generic Injectables As First Launches of 2020
MANALAPAN, N.J., Jan. 20, 2020 -- (Healthcare Sales & Marketing Network) -- Armas Pharmaceuticals Inc. (Armas), has begun the new year with launches of four generic injectables: Caffeine Citrate, Docetaxel, Gemcitabine and Verapamil HCI. These products ar... Biopharmaceuticals, Generics, Product Launch Armas Pharmaceuticals, CAFCIT, Taxotere, Gemzar, Verapamil (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2020 Category: Pharmaceuticals Source Type: news
Verapamil and Cluster Headache: Still a Mystery Verapamil and Cluster Headache: Still a Mystery
Verapamil has been used for the prophylaxis of cluster headache for decades--but we still don ' t know why it works.Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 18, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Effect of CYP3A4 inhibitors verapamil and itraconazole on the pharmacokinetics of AZD7986, an oral DPP1 inhibitor
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news
verapamil (Calan, Verelan, Verelan PM [Discontinued: Isoptin, Isoptin SR, Covera-HS])
Title: verapamil (Calan, Verelan, Verelan PM [Discontinued: Isoptin, Isoptin SR, Covera-HS])Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/2/2019 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - August 2, 2019 Category: Cardiology Source Type: news
Verapamil HCl Extended-Release Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 22, 2019 Category: Drugs & Pharmacology Source Type: news
Verapamil Hydrochloride (Verapamil Hydrochloride Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 30, 2018 Category: Drugs & Pharmacology Source Type: news
UAB researchers make big discovery on diabetes research
Researchers at the UAB ’s comprehensive Diabetes Center have discovered a safe and effective therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset Type 1 diabetes by promoting the patient’s own beta cell function and insulin production – the first such discovery to targ et diabetes in this way.
The findings reveal that regular oral application of verapamil, a common blood pressure medication, also enabled patients to produce higher levels of their… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 16, 2018 Category: Biotechnology Authors: Tyler Patchen Source Type: news
UAB researchers make big discovery on diabetes research
Researchers at the UAB ’s comprehensive Diabetes Center have discovered a safe and effective therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset Type 1 diabetes by promoting the patient’s own beta cell function and insulin production – the first such discovery to targ et diabetes in this way.
The findings reveal that regular oral application of verapamil, a common blood pressure medication, also enabled patients to produce higher levels of their… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 16, 2018 Category: American Health Authors: Tyler Patchen Source Type: news
Verapamil Success for T1D; Bariatric Surgery Wait; Self-Monitoring Without Insulin?
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 13, 2018 Category: Cardiology Source Type: news
